Table 3—

American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders criteria for considering corticosteroid treatment in sarcoidosis

Progressive symptomatic pulmonary disease
Asymptomatic pulmonary disease with persistent infiltrates or progressive loss of lung function
Cardiac disease
Neurological disease
Eye disease not responding to topical therapy
Symptomatic hypercalcaemia
Other symptomatic/progressive extrapulmonary disease